Global /China /Healthcare /Drug Manufacturers - General /002793

Luoxin Pharmaceuticals Group Stock Co., Ltd.

002793

• SHE: 002793 • Delayed

5.53CNY 2.6%

0.8183 USD

As of 19 June 2026, Luoxin Pharmaceuticals Group Stock Co., Ltd. has a market cap of $867.41M USD, ranking #11583 globally and #3372 in China. It ranks #1051 in the Healthcare sector, and #395 in the Drug Manufacturers - General industry.

Global Rank

11583

Country Rank

3372

Sector Rank

1051

Industry Rank

395

Key Stats

Market Cap

$867.41MUSD

5.86B CNY

Enterprise Value

$958.56MUSD

6.48B CNY

Revenue (TTM)

$351.2MUSD

2.37B CNY

EBITDA (TTM)

$11.75MUSD

79.4M CNY

Net Income (TTM)

-$39.96MUSD

-270.08M CNY

EBITDA Margin

3.3%

Profit Margin

-11%

PS Ratio

2.5

PB Ratio

5.0

EV/EBITDA

142.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Zhenteng Liu open_in_new

Employees

3,196

Founded

1998

Website

luoxin.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.6%	-2%	15%	13%	4.9%	15%	24%	-22%	-45%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002793 罗欣药业集团股份有限公司 Class A ISIN: CNE1000026S7 Shares Out.: Shares Outstanding: 1.088B¹ Shares Float: 465.262M² TV: TradingView: SZSE: 002793 SA: Stock Analysis: SHE: 002793 YF: Yahoo Finance: 002793.SZ GF: Google Finance: SHE: 002793 BA: Barron's: 002793 MS: Morningstar: XSHE: 002793	5.53 CNY	TV: TradingView: SZSE: 002793 SA: Stock Analysis: SHE: 002793 YF: Yahoo Finance: 002793.SZ GF: Google Finance: SHE: 002793 BA: Barron's: 002793 MS: Morningstar: XSHE: 002793

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Luoxin Pharmaceuticals Group Stock Co., Ltd.

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. The company was founded in 1998 and is based in Linyi, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.99B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.77B 336.36B CNY 6K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.56B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 88K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 63K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 41K%	97.4	United States
Roche Holding AG SIX: RO	$321.45B 256.25B CHF 37K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.52B 215.59B GBP 33K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.59B 218.9B CHF 32K%	20.5	Switzerland

chevron_leftBack